PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy.
J Hepatol. 2022 Jul;77(1):140-151. doi: 10.1016/j.jhep.2022.01.026. Epub 2022 Feb 12.
J Hepatol. 2022.
PMID: 35157958